Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
SAN ANTONIO, March 26, 2025--bioAffinity Technologies' CyPath Lung test uncovered a hidden second primary lung cancer in a patient who had been treated for lung cancer earlier.
Business Wire11d
Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence
A PET scan was unlikely to provide clarity due ... been part of the standard of care for Medicare patients with a positive lung cancer screening, for a total of $379 million.
standardmedia.co.ke7mon
Understanding your chest CT and PET scans in lung cancer detection
To explain the nuances of lung cancer imaging ... by detecting minute changes in glucose metabolism, a PET scan can pick up on positive treatment effects even before the tumour starts to shrink.
Multimodal Multitask Foundation Model Enhances Lung Cancer Screening and Beyond
A new study published in Nature Communications introduces a multimodal multitask foundation model that significantly enhances ...
Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence
In another case study, CyPath® Lung helped physicians identify and treat a recurrence of breast cancer in a high-risk patient.